CJ Health Care held co-promotion agreement signing ceremony of
On Apr 14, CJ Health Care held co-promotion agreement signing ceremony of "Forxiga (ingredient: dapagliflozin)" which is Korea's first approved SGLT-2 inhibitors diabetes treatment, with AstraZeneca Korea in CJ Healthcare.
The two companies will jointly conduct sales and marketing of the product...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
